A New Neolignan Derivative, Balanophonin Isolated from Firmiana simplex Delays the Progress of Neuronal Cell Death by Inhibiting Microglial Activation

다국어 초록 (Multilingual Abstract)

Excessive activation of microglia causes the continuous production of neurotoxic mediators, which further causes neuron degeneration.
Therefore, inhibition of microglial activation is a possible target for the treatment of neurodegenerative disorders.
Balanophonin, a natural neolignoid from Firmiana simplex, has been reported to have anti-inflammatory and anti-cancer effects. In this study, we aimed to evaluate the anti-neuroinflammatory effects and mechanism of balanophonin in lipopolysaccharide (LPS)- stimulated BV2 microglia cells. BV2 microglia cells were stimulated with LPS in the presence or absence of balanophonin. The results indicated that balanophonin reduced not only the LPS-mediated TLR4 activation but also the production of inflammatory mediators, such as nitric oxide (NO), prostaglandin E2 (PGE2), Interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α), in BV2 cells. Balanophonin also inhibited LPS-induced inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX2) protein expression and mitogen activated protein kinases (MAPKs), including extracellular signal-regulated kinase (ERK1/2), c-Jun Nterminal kinase (JNK), and p38 MAPK. Interestingly, it also inhibited neuronal cell death resulting from LPS-activated microglia by regulating cleaved caspase-3 and poly ADP ribose polymerase (PARP) cleavage in N2a cells. In conclusion, our data indicated that balanophonin may delay the progression of neuronal cell death by inhibiting microglial activation.

참고문헌 (Reference)

1 Waetzig, V., "c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia" 50 : 235-246, 2005

2 Woo, K. W., "Ursane saponins from the stems of Firmiana simplex and their cytotoxic activity" 26 : 1450-1456, 2015

3 Lynch, M. A., "The multifaceted profile of activated microglia" 40 : 139-156, 2009

4 McGeer, P. L., "The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases" 21 : 195-218, 1995

5 da Fonseca, A. C., "The impact of microglial activation on blood-brain barrier in brain diseases" 8 : 362-, 2014

6 Sánchez-Pernaute, R., "Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson’s disease" 1 : 6-, 2004

7 Liu, B., "Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention" 304 : 1-7, 2003

8 Tang, Q., "Removal of Cd(II) from aqueous solution with activated Firmiana Simplex Leaf: behaviors and affecting factors" 179 : 95-103, 2010

9 Hanada, T., "Regulation of cytokine signaling and inflammation" 13 : 413-421, 2002

10 Murphy, S., "Production of nitric oxide by glial cells: regulation and potential roles in the CNS" 29 : 1-13, 2000

11 Tu, Y. F., "Overweight worsens apoptosis, neuroinflammation and blood-brain barrier damage after hypoxic ischemia in neonatal brain through JNK hyperactivation" 8 : 40-, 2011

12 Klegeris, A., "Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease" 2 : 355-365, 2005

13 Lee, H. S., "Neuroprotective effect of curcumin is mainly mediated by blockade of microglial cell activation" 62 : 937-942, 2007

14 Sairanen, T., "Neuronal caspase-3 and PARP-1 correlate differentially with apoptosis and necrosis in ischemic human stroke" 118 : 541-552, 2009

15 Kreutzberg, G. W., "Microglia: a sensor for pathological events in the CNS" 19 : 312-318, 1996

16 김윤성, "Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson’s disease" 생화학분자생물학회 38 (38): 333-347, 2006

17 Minghetti, L., "Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide" 54 : 99-125, 1998

18 Block, M. L., "Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism" 76 : 77-98, 2005

19 Kaminska, B., "MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits" 1754 : 253-262, 2005

20 Campbell, A., "Inflammation, neurodegenerative diseases, and environmental exposures" 1035 : 117-132, 2004

21 McGeer, P. L., "Inflammation of the brain in Alzheimer’s disease: implications for therapy" 65 : 409-415, 1999

22 McGeer, P. L., "Inflammation and neurodegeneration in Parkinson’s disease" 10 : S3-S7, 2004

23 Kim, S. H., "Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1βproduction" 25 : 431-439, 2004

24 Kim, J. W., "Hepatoprotective constituents of Firmiana simplex stem bark against ethanol insult to primary rat hepatocytes" 11 : 55-60, 2015

25 Lee, H., "Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia" 17 : 1943-1944, 2003

26 Zhang, L. -X., "Emergency evaluation of environmental sustainability of poultry farming that produces products with organic claims on the outskirts of mega-cities in China" 54 : 128-135, 2013

27 Tripathi, S., "Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages" 138 : 209-213, 2007

28 Cao, J., "Distinct requirements for p38α and c-Jun Nterminal kinase stress-activated protein kinases in different forms of apoptotic neuronal death" 279 : 35903-35913, 2004

29 Liu, Y., "Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation" 305 : 212-218, 2003

30 Minghetti, L., "Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases" 63 : 901-910, 2004

31 Yang, S., "Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture" 33 : 2044-2053, 2008

32 St-Onge, M., "Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils" 1771 : 1235-1245, 2007

33 Burguillos, M. A., "Caspase signalling controls microglia activation and neurotoxicity" 472 : 319-324, 2011

34 Robitaille, K., "Calphostin C-induced apoptosis is mediated by a tissue transglutaminase-dependent mechanism involving the DLK/JNK signaling pathway" 15 : 1522-1531, 2008

35 Rankine, E. L., "Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment" 24 : 77-86, 2006

36 Woo, K. W., "Bioactive lignan derivatives from the stems of Firmiana simplex" 26 : 730-733, 2016

37 Ha, S. K., "Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model" 52 : 878-886, 2008

38 Li, Z., "Activation of firmiana simplex leaf and the enhanced Pb(II) adsorption performance:equilibrium and kinetic studies" 169 : 386-394, 2009

39 Xie, Z., "Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38" 45 : 170-179, 2004

40 Yeon Kyoung Son, "A New Antipsychotic Effective Neolignan from Firmiana simplex" 대한약학회 28 (28): 34-38, 2005

41 Ha, S. K., "6-Shogaol, a ginger product, modulates neuroinflammation:a new approach to neuroprotection" 63 : 211-223, 2012